Search research articles
Contact Us
Filters
Showing results (121-130 of 139) with videos related to
Page
of 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2023
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
J Remon, B Besse, S Ponce Aix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients
J Chen, F Facchinetti, F Braye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2022
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors
F Peyraud, J-P Guégan, D Bodet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2026
Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?
A Mavrikios, M Bortolot, C Le Péchoux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 13, 2023
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
B Besse, E Felip, R Garcia Campelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 9, 2012
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF)
S Couraud, A B Cortot, L Greillier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
C R Lindsay, F H Blackhall, A Carmel, et al.
Revue Des Maladies Respiratoires
|
January 28, 2014
[Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française]
N Girard, V Gounant, B Mennecier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2025
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancer
B Ricciuti, S Scalera, X Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2013
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
M Beau-Faller, N Prim, A-M Ruppert, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 139) with videos related to
Sort By:
Page
of 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2023
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
J Remon, B Besse, S Ponce Aix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients
J Chen, F Facchinetti, F Braye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2022
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors
F Peyraud, J-P Guégan, D Bodet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2026
Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?
A Mavrikios, M Bortolot, C Le Péchoux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 13, 2023
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
B Besse, E Felip, R Garcia Campelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 9, 2012
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF)
S Couraud, A B Cortot, L Greillier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
C R Lindsay, F H Blackhall, A Carmel, et al.
Revue Des Maladies Respiratoires
|
January 28, 2014
[Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française]
N Girard, V Gounant, B Mennecier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 20, 2025
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancer
B Ricciuti, S Scalera, X Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2013
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
M Beau-Faller, N Prim, A-M Ruppert, et al.
Page
of 14